全文获取类型
收费全文 | 3674篇 |
免费 | 384篇 |
国内免费 | 84篇 |
专业分类
耳鼻咽喉 | 91篇 |
儿科学 | 203篇 |
妇产科学 | 43篇 |
基础医学 | 854篇 |
口腔科学 | 56篇 |
临床医学 | 186篇 |
内科学 | 713篇 |
皮肤病学 | 149篇 |
神经病学 | 466篇 |
特种医学 | 50篇 |
外科学 | 312篇 |
综合类 | 247篇 |
预防医学 | 69篇 |
眼科学 | 245篇 |
药学 | 85篇 |
2篇 | |
中国医学 | 8篇 |
肿瘤学 | 363篇 |
出版年
2023年 | 78篇 |
2022年 | 49篇 |
2021年 | 119篇 |
2020年 | 151篇 |
2019年 | 151篇 |
2018年 | 136篇 |
2017年 | 119篇 |
2016年 | 141篇 |
2015年 | 158篇 |
2014年 | 188篇 |
2013年 | 247篇 |
2012年 | 186篇 |
2011年 | 146篇 |
2010年 | 114篇 |
2009年 | 180篇 |
2008年 | 142篇 |
2007年 | 175篇 |
2006年 | 194篇 |
2005年 | 178篇 |
2004年 | 159篇 |
2003年 | 122篇 |
2002年 | 135篇 |
2001年 | 110篇 |
2000年 | 78篇 |
1999年 | 63篇 |
1998年 | 51篇 |
1997年 | 52篇 |
1996年 | 31篇 |
1995年 | 64篇 |
1994年 | 44篇 |
1993年 | 32篇 |
1992年 | 30篇 |
1991年 | 25篇 |
1990年 | 25篇 |
1989年 | 33篇 |
1988年 | 27篇 |
1987年 | 23篇 |
1986年 | 14篇 |
1985年 | 27篇 |
1984年 | 19篇 |
1983年 | 11篇 |
1982年 | 13篇 |
1981年 | 20篇 |
1980年 | 14篇 |
1979年 | 11篇 |
1978年 | 16篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1974年 | 6篇 |
1970年 | 6篇 |
排序方式: 共有4142条查询结果,搜索用时 15 毫秒
1.
《Archivos de la Sociedad Espa?ola de Oftalmología》2022,97(4):219-223
Full-thickness macular hole is a rare complication of macular telangiectasia type 2, and its treatment is still controversial. A patient with a full-thickness macular hole secondary to macular telangiectasia type 2 underwent vitreoretinal surgery with a plasma rich in growth factors membrane in the macular hole. At the sixth month of follow-up, anatomical and functional improvements were achieved, with no adverse effects. Plasma rich in growth factors is a new option, with advantages due to its biological properties that achieves good results in terms of safety and effectiveness in the surgical treatment of macular hole. 相似文献
2.
3.
《European journal of medical genetics》2022,65(10):104575
Hereditary haemorrhagic telangiectasia (HHT) is a rare vascular multisystemic disease that leads to epistaxis, anaemia due to blood loss, and arteriovenous malformations (AVMs) in organs such as the lungs, liver and brain. HHT prevalence is estimated at 1/6000, i.e. around 85,000 European citizens, and is served by the European Reference Network for Rare Multisystemic Vascular Diseases (VASCERN). HHT treatments depend on clinical manifestations, and span multiple different medical, surgical and interventional disciplines. Separate to local treatments in the nose, in severe settings, intravenous bevacizumab has been proposed as treatment option, and the purpose of the current article is to assess the use of intravenous bevacizumab in patients with HHT in 2022 according to available data. 相似文献
4.
5.
Leyi Wang Saraswathi Lanka Debbie Cassout Nohra E. Mateus‐Pinilla Ganwu Li William C. Wilson Dongwan Yoo Paul Shelton Richard L. Fredrickson 《Transboundary and Emerging Diseases》2019,66(5):1809-1820
First described in 1955 in New Jersey, epizootic haemorrhagic disease (EHD) causes a severe clinical disease in wild and domestic ruminants worldwide. Epizootic haemorrhagic disease outbreaks occur in deer populations each year from summer to late autumn. The etiological agent is EHD virus (EHDV) which is a double‐stranded segmented icosahedral RNA virus. EHD virus utilizes point mutations and reassortment strategies to maintain viral fitness during infection. In 2018, EHDV serotype 2 was predominantly detected in deer in Illinois. Whole genome sequencing was conducted for two 2018 EHDV2 isolates (IL41747 and IL42218) and the sequence analyses indicated that IL42218 was a reassortant between different serotypes whereas IL41747 was a genetically stable strain. Our data suggest that multiple strains contribute to outbreaks each year. 相似文献
6.
Russell G. Witt MD MAS Elizabeth H. Baldini MD MPH Chandrajit P. Raut MD MSc 《Journal of surgical oncology》2019,120(5):882-890
Soft tissue sarcomas (STS) are a rare and diverse group of tumors that affect both adult and pediatric populations. This review discusses current screening recommendations for populations at increased risk for STS, including those with genetic predispositions. We also review surveillance guidelines for those at risk for recurrence following curative-intent surgery. 相似文献
7.
Silmara P. Gouvea Pedro J. Tomaselli Luiza S. Barretto Keity C. B. Perina Fulviana S. Nyshyama Nilson Nicolau Charles M. Loureno Wilson Marques 《Journal of the peripheral nervous system : JPNS》2019,24(2):207-212
Mutations in the GJB1 gene are the second most frequent cause of Charcot‐Marie‐Tooth disease (CMT), accounting for approximately 10% of CMT cases worldwide. We retrospectively analyzed detailed clinical and neurophysiological data on four Brazilian families carrying novel mutations of the GJB1 gene. Mutations were identified by bidirectional Sanger sequence analysis on the GJB1 coding region. We identified a total of 12 subjects from four different kindred. There was no male‐to‐male transmission, and their clinical pictures were within the expected spectrum for GJB1‐related neuropathy. Males were more severely affected than females. Five out of the eight females only had subclinical neuropathy. Nerve conduction velocities were in the intermediate range in the male patients and higher in the females affected. These mutations increase the genotypic variability associated with GJB1. 相似文献
8.
9.
目的分析SLC4A1复合杂合突变致遗传性球形红细胞增多症(HS)并远端肾小管酸中毒(dRTA)的临床表型与基因变异的关系。方法回顾分析1例确诊HS合并dRTA患儿的临床资料,以及患儿及父母外周血全外显子测序及Sanger验证结果。结果男性患儿,1岁7个月,主要临床表现为输血依赖性球形红细胞增多、代谢性酸中毒、低钾血症及生长发育迟缓。检测到患儿SLC4A1 基因2个已报道的错义变异c.2102GA p.(Gly701Asp),c.1988TC p.(Met663Thr),分别来源于父母。结论经基因检测确诊由SLC4A1复合杂合变异所致的遗传型HS合并dRTA,符合常染色体隐性遗传。 相似文献
10.